Nkarta Inc (NKTX)
6.52
-0.30
(-4.40%)
USD |
NASDAQ |
May 17, 16:00
6.52
0.00 (0.00%)
After-Hours: 20:00
Nkarta Total Liabilities (Quarterly): 103.28M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 103.28M |
| December 31, 2023 | 105.60M |
| September 30, 2023 | 109.05M |
| June 30, 2023 | 111.06M |
| March 31, 2023 | 111.52M |
| December 31, 2022 | 100.73M |
| September 30, 2022 | 104.54M |
| June 30, 2022 | 82.60M |
| March 31, 2022 | 77.59M |
| Date | Value |
|---|---|
| December 31, 2021 | 22.94M |
| September 30, 2021 | 22.45M |
| June 30, 2021 | 20.73M |
| March 31, 2021 | 19.70M |
| December 31, 2020 | 16.43M |
| September 30, 2020 | 17.31M |
| June 30, 2020 | 127.50M |
| March 31, 2020 | 15.00M |
| December 31, 2019 | 73.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.00M
Minimum
Mar 2020
127.50M
Maximum
Jun 2020
69.00M
Average
80.10M
Median
Total Liabilities (Quarterly) Benchmarks
| Cutera Inc | 504.56M |
| GT Biopharma Inc | 6.633M |
| Outlook Therapeutics Inc | 193.26M |
| IMAC Holdings Inc | 1.897M |
| Capricor Therapeutics Inc | 31.01M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 576.94M |
| Shareholders Equity (Quarterly) | 473.65M |